• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconValeant

Valeant

Page 6 of 12
Investors in Female Viagra Are Slamming Valeant
Finance
Investors in Female Viagra Are Slamming Valeant
By Lucinda ShenMarch 25, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Finance
Bill Ackman Asked for Information in Drug Pricing Probe
By ReutersMarch 24, 2016
Trading At The NYSE As Valeant Shares Halted Ahead of News Announcement
Finance
The Head of a Buffett-Linked Fund Just Resigned Over Its Huge Valeant Stake
By Sy MukherjeeMarch 24, 2016
Trading At The NYSE As Valeant Shares Halted Ahead of News Announcement
Finance
The Really Big Problem with Valeant’s Billions of Debt
By Lauren Silva LaughlinMarch 22, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Finance
Here’s Why Valeant May Have Accused Its Former CFO of “Improper Conduct”
By ReutersMarch 21, 2016
Drug Hearing
Finance
Valeant Infighting Is Getting Nasty
By Jen WiecznerMarch 21, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Health
Valeant Is Looking For a New CEO
By Phil WahbaMarch 21, 2016
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., speaks during their annual general meeting in Laval, Quebec
Finance
What Caused Valeant’s Epic 90% Plunge
By Stephen Gandel and ReutersMarch 20, 2016
Key Speakers At The Bloomberg Markets Most Influential Summit
Finance
This Valeant Investor Is In Even Bigger Trouble than Bill Ackman
By Jen WiecznerMarch 18, 2016
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Finance
Valeant CEO Promises Company Won’t Go Bankrupt in Staff Memo
By Jen WiecznerMarch 18, 2016
Key Speakers At The Bloomberg Markets Most Influential Summit
Finance
Ackman’s Hedge Fund Faces S&P Downgrade
By ReutersMarch 17, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Finance
Here’s Why Valeant Shares Plummeted Again
By Laura LorenzettiMarch 17, 2016
House Oversight Hearing On Prescription Drug Price Increases
Health
Martin Shkreli’s Former Colleague: We Advised Him Against That Infamous Price Hike
By Sy MukherjeeMarch 17, 2016
Hedge fund manager Bill Ackman
Finance
Ackman Sells Big Mondelez Stake Amid Major Losses
By ReutersMarch 16, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Leadership
Valeant to Walgreens: Hey, It’s Not Your Fault After All
By Jennifer ReingoldMarch 16, 2016
1...
  • 4
  • 5
  • 6
  • 7
  • 8
...12
Most Popular
Big Tech
As Big Tech showers employees with perks to win the talent war, Nvidia built a nearly $5 trillion company by making people pay for their own lunchplaceholder alt text
By Marco Quiroz-GutierrezJuly 1, 2026
Success
MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last yearplaceholder alt text
By Sydney LakeJune 25, 2026
Success
Philanthropy leader at Warren Buffett and Bill Gates’ Giving Pledge says children of billionaires are pushing them to give their wealth away fasterplaceholder alt text
By Preston ForeJune 27, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.